ACE and triple-A syndrome: The association of antiplatelet use with faster AAA growth may relate to an absence of treatment with other cardiometabolic medications, rather than harmful effects of the medications themselves, as it was found that participants were more likely to be taking antiplatelets if they were not taking ACE inhibitors, ARBs, metformin, and thiazides.